Search by Drug Name or NDC

NDC 68968-0172-03 SECUADO 3.8 mg/d Details

SECUADO 3.8 mg/d

SECUADO is a TRANSDERMAL FILM, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Noven Therapeutics, LLC. The primary component is ASENAPINE.

MedlinePlus Drug Summary

Asenapine transdermal patches are used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Asenapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Related Packages: 68968-0172-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Asenapine Transdermal Patch

Product Information

NDC	68968-0172
Product ID	68968-0172_f98aaf2b-9c84-489d-9693-49b246c37aac
Associated GPIs	59155015008520
GCN Sequence Number	080406
GCN Sequence Number Description	asenapine PATCH TD24 3.8MG/24HR TRANSDERM
HIC3	H7T
HIC3 Description	ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
GCN	47229
HICL Sequence Number	046175
HICL Sequence Number Description	ASENAPINE
Brand/Generic	Brand
Proprietary Name	SECUADO
Proprietary Name Suffix	n/a
Non-Proprietary Name	ASENAPINE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	FILM, EXTENDED RELEASE
Route	TRANSDERMAL
Active Ingredient Strength	3.8
Active Ingredient Units	mg/d
Substance Name	ASENAPINE
Labeler Name	Noven Therapeutics, LLC
Pharmaceutical Class	Atypical Antipsychotic [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA212268
Listing Certified Through	2024-12-31

Package

NDC 68968-0172-03 (68968017203)

Pricing Information	N/A
NDC Package Code	68968-0172-3
Billing NDC	68968017203
Package	30 POUCH in 1 CARTON (68968-0172-3) / 1 d in 1 POUCH
Marketing Start Date	2020-02-12
NDC Exclude Flag	N